The cardiac amyloidosis program at Cedars-Sinai is a destination for exceptional care. We are among the few programs on the West Coast using a comprehensive, multidisciplinary approach. A support group is available to help patients and their families navigate the challenges of a cardiac amyloidosis diagnosis. We are also among a select group of programs where you’ll find clinical trials.

You have access to sophisticated testing, advanced treatments and life-saving care from a single team. Cedars-Sinai is home to an internationally renowned cardiac amyloidosis expert team of specialists in imaging, pathology, amyloidosis, hematology, nephrology, neurology, gastroenterology, supportive care, genetic counseling, cardiomyopathy and genetics. We deliver a level of care that draws patients from across the country.

Conditions We Treat

Cardiac amyloidosis is a rare disease that often goes undetected as a cause of heart failure. Many people do not experience symptoms in the early stages. This condition may have no known cause, occur with age or be passed down in families (familial amyloidosis).

Amyloid buildups grow over time which can lead to heart failure and other life-threatening complications. There is no cure, but treatments may slow disease progression and provide relief from side effects.

Related Programs and Services

You benefit from a highly skilled team of specialists experienced in the unique needs of cardiac amyloidosis patients. Those specialists come from a wide variety of programs, including:

Clinical Trials

We are advancing cardiac amyloidosis care through clinical trials and research as members of a consortium of cardiac amyloidosis centers. You have the option of participating in these efforts through our clinical trials. Becoming part of a clinical trial gives you access to new drug therapies, in some cases, years before they become widely available.